Literature DB >> 16916948

Decreased glucagon responsiveness by bile acids: a role for protein kinase Calpha and glucagon receptor phosphorylation.

Tadashi Ikegami1, Lada Krilov, Jianping Meng, Bhumika Patel, Kelli Chapin-Kennedy, Bernard Bouscarel.   

Abstract

Dihydroxy bile acids like chenodeoxycholic acid (CDCA) induce heterologous glucagon receptor desensitization. We previously demonstrated that protein kinase C (PKC) was activated by certain bile acids and mediated the CDCA-induced decrease in glucagon responsiveness. The aim of the present study was to explore the role of PKC in the phosphorylation and desensitization of the glucagon receptor by CDCA. Desensitization was evaluated by measuring adenylyl cyclase activity. Receptor phosphorylation was assayed by metabolic labeling with [gamma-(32)P] ATP. Protein kinase C (PKC) translocation and activation was visualized by fluorescence microscopy. CDCA decreased cAMP production induced by glucagon in a dose-dependent manner without affecting cAMP synthesis through stimulation of either stimulatory GTP-binding protein (Gs) by NaF or adenylyl cyclase by forskolin. The CDCA-induced inhibition of adenylyl cyclase activity was potentiated by the phosphatase inhibitor, okadaic acid. The desensitizing effect of CDCA was bile acid-specific and was significantly reduced in the presence of PKC inhibitors and after PKC down-regulation by phorbol 12-myristate 13-acetate. CDCA increased glucagon receptor phosphorylation more than 3-fold at concentrations as low as 25 mum. Furthermore, CDCA significantly stimulated human recombinant PKCalpha autophosphorylation in vitro, as well as PKCalpha translocation to the plasma membrane and phosphorylation in vivo at concentrations as low as 25 mum. CDCA also stimulated PKCdelta translocation to the perinuclear region. Activated PKCalpha, PKCzeta, and to a lesser extent, PKCdelta, phosphorylated the glucagon receptor in vitro. This study demonstrates that certain bile acids, such as CDCA, stimulate phosphorylation and heterologous desensitization of the glucagon receptor, involving at least PKCalpha activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916948     DOI: 10.1210/en.2006-0516

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Russell Williams; Norman H Lee; Susan Ceryak; Bernard Bouscarel
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

2.  Hepatic mTORC2 Signaling Facilitates Acute Glucagon Receptor Enhancement of Insulin-Stimulated Glucose Homeostasis in Mice.

Authors:  Teayoun Kim; Shelly Nason; Jessica Antipenko; Brian Finan; Anath Shalev; Richard DiMarchi; Kirk M Habegger
Journal:  Diabetes       Date:  2022-10-01       Impact factor: 9.337

Review 3.  Elusive liver factor that causes pancreatic α cell hyperplasia: A review of literature.

Authors:  Run Yu; Yun Zheng; Matthew B Lucas; Yun-Guang Tong
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

4.  cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 beta/alpha in rat hepatocytes.

Authors:  Anna Gates; Simon Hohenester; M Sawkat Anwer; Cynthia R L Webster
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-05       Impact factor: 4.052

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.